Journal
CELLULAR SIGNALLING
Volume 27, Issue 3, Pages 652-662Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.cellsig.2014.11.028
Keywords
Tumor suppressor KAI1 (CD82) and its splice variant; Integrin alpha v beta 3; Ovarian cancer cell adhesion, motility, and proliferation; Epidermal growth factor receptor (promoter); E-cadherin
Categories
Ask authors/readers for more resources
Loss or downregulation of the tumor-suppressor KAI1 correlates with poor cancer patient prognosis. KAI1 functions by interacting with other proteins, including integrin cell adhesion and signaling receptors. We previously showed that KAI1 physically and functionally crosstalks with the tumor-biologically relevant integrin alpha v beta 3, thereby suppressing ovarian cancer cell migration and proliferation. Interestingly, in metastases, a KAI1 splice variant had been identified, indicating poor patient prognosis. Thus, we here characterized differential effects of the two KAI1 proteins upon their cellular restoration. Opposite to KAI1, KAI1-splice reduced alpha v beta 3-mediated cell adhesion, thereby inducing cell migration. This was accompanied by elevated alpha v beta 3 levels and drastically elevated focal adhesion kinase activation, however, without any obvious colocalization with alpha v beta 3, as observed for KAI1. Moreover, codistribution of KAI1 with the cell/cell-adhesion molecule E-cadherin was abrogated in KAI1-splice. Whereas KAI1 diminished cell proliferative activity, KAI1-splice prominently enhanced cell proliferation concomitant with elevated transcription and cell-surface expression of the epidermal growth factor receptor. Thus KAI1-splice does not only counteract the tumor-suppressive actions of KAI1, but - beyond that - promotes alpha v beta 3-mediated biological functions in favor of tumor progression and metastasis. (C) 2014 Elsevier Inc All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available